Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.993 EUR | +1.85% |
|
+6.56% | -20.73% |
Jul. 01 | Enzo Biochem, Inc.(NYSE:ENZ) dropped from Russell Microcap Growth Index | CI |
Jul. 01 | Enzo Biochem, Inc.(NYSE:ENZ) dropped from Russell 3000E Growth Index | CI |
Sales 2022 | 107M 98.63M | Sales 2023 | 31.06M 28.61M | Capitalization | 73.6M 67.8M |
---|---|---|---|---|---|
Net income 2022 | -18M -16.58M | Net income 2023 | 20M 18.42M | EV / Sales 2022 | 1.07 x |
Net cash position 2022 | 1.02M 936K | Net cash position 2023 | 75.38M 69.43M | EV / Sales 2023 | -0.06 x |
P/E ratio 2022 |
-6.24
x | P/E ratio 2023 |
3.59
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 75.92% |
1 week | +6.56% | ||
Current month | +3.17% | ||
1 month | -8.88% | ||
3 months | -11.36% | ||
6 months | -22.00% | ||
Current year | -20.73% |
![Extreme 0.92](/images/extremecours_fleche.png)
![Extreme 0.915](/images/extremecours_fleche.png)
![Extreme 0.915](/images/extremecours_fleche.png)
![Extreme 0.915](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Kara Cannon
CEO | Chief Executive Officer | 56 | 10-12-31 |
Elazar Rabbani
FOU | Founder | 81 | 76-07-31 |
Patricia Eckert
DFI | Director of Finance/CFO | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Pully
CHM | Chairman | 64 | 23-10-25 |
Mary Tagliaferri
BRD | Director/Board Member | 58 | 20-11-16 |
Bradley Radoff
BRD | Director/Board Member | 50 | 22-01-02 |
Date | Price | Change |
---|---|---|
24-07-11 | 0.98 | +0.51% |
24-07-10 | 0.975 | +3.17% |
24-07-09 | 0.945 | +0.53% |
24-07-08 | 0.94 | +2.17% |
24-07-05 | 0.92 | -0.54% |
Delayed Quote Börse Stuttgart, July 11, 2024 at 04:40 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+18.09% | 45.01B | |
+45.49% | 40.96B | |
-8.38% | 38.62B | |
+34.66% | 32.6B | |
-8.34% | 27.49B | |
+16.10% | 27.17B | |
+49.73% | 14.61B | |
+36.71% | 12.95B | |
-6.60% | 11.36B |
- Stock Market
- Equities
- ENZ Stock
- EZB Stock